The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

Obesity is a systemic disease of the white adipose tissue, which has evolved into a global
epidemic. It is associated with a plethora of adipocyte hormonal (adipokine) imbalances …

Hypertension (HTN) and CKD are closely associated with an intermingled cause and effect
relationship. Blood pressure (BP) typically rises with declines in kidney function, and …

Obesity, the epidemic of the 21st century, carries a markedly increased risk for comorbid
complications, such as type 2 diabetes, cancer, hypertension, dyslipidemia, cardiovascular …

In the United States the prevalence of end-stage renal disease (ESRD) reached epidemic
proportions in 2012 with over 600,000 patients being treated. The rates of ESRD among the …

Pulmonary arterial hypertension is a rare disease often associated with positive antinuclear
antibody and high mortality. Pulmonary hypertension, which rarely is severe, occurs …

Background Sleep apnea is an important comorbidity in patients with chronic kidney disease
(CKD) and end-stage renal disease (ESRD). Although the increased prevalence of sleep …

Chronic kidney disease (CKD) is associated with high mortality rates and heavy economic
and social burdens. Nearly 10% of the United States population suffer from CKD, with fatal …

Patients with chronic kidney disease have increased morbidity and mortality, mainly due to
cardiovascular disease. Compared with the general population, patients with chronic kidney …

Patients with advanced chronic kidney disease (CKD) experience multiple bothersome
symptoms, undermining their quality of life (QOL). With growing attention to the importance …